title: Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia.
authors.forename: J
authors.initials: J
authors.lastname: Moravcová
authors.forename: S
authors.initials: S
authors.lastname: Nádvorníková
authors.forename: M
authors.initials: M
authors.lastname: Lukásová
authors.forename: H
authors.initials: H
authors.lastname: Klamová
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D016044:Fusion Proteins, bcr-abl / Q000032:analysis / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis*; D018365:Neoplasm, Residual / Q000175:diagnosis; D016133:Polymerase Chain Reaction / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl